US equities |
NVDA $236.82 ▲+1.23% SPCX $166.96 ▲+5.03% MU $1,067.19 ▼-0.72% TSLA $377.61 ▲+1.89% MSFT $526.72 ▲+1.78% INTC $117.26 ▼-1.73% SNDK $1,730.08 ▲+0.59% META $742.74 ▲+2.01%
FinancialContent

Lifeward Ltd. - Ordinary Shares (NQ:LFWD)

6.216 +0.366 (+6.25%)
Delayed Quote Updated: 10:17 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lifeward Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
News headline image
Lifeward to Report First Quarter Financial Results on May 15, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors
Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries 
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
Unleashing the Underdogs: 3 Hidden Gems Set to Conquer the Market ↗
Dive into the success stories of these hidden gem stocks that will conquer the market as they transforming their respective industries. 
Via InvestorPlace
News headline image
Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
Lifeward Announces Reverse Share Split
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
ReWalk Robotics Q4 Earnings Miss Estimates, Issues FY24 Guidance ↗
ReWalk Robotics reports Q4 earnings below estimates, with revenue miss; forecasts lower-than-expected revenue for FY24. 
Via Benzinga
Topics Earnings
News headline image
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
News headline image
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >